Контрацепция: литература

1. Каткова И.П. и соавт. Медико-социальные проблемы юного материнства. М 1992.

2. Корхов В.В. Медицинские аспекты применения контрацептивных препаратов. "Специальная литература" С-Пб 1996; 5.

3. Маллер Х. Преграды на пути репродуктивного выбора. Планирование семьи 1/1993; 22-24.

4. Материалы предоставлены компанией "Органон", 1998.

5. Cметник В.И., Тумилович Л.Г. Неоперативная гинекология. М 1997.

6. Baird D.T. Mechanism of action of antigestogens on the ovary and utrus. Abstract SE77.1. XV FIGO World Congress of Gynecology and Obstetrics, 1997.

7. Brown G.F. et al. Moral and policy issues in long-acting contracepion. Annu Rev Public Health 1997; 18: 379-400.

8. Bygdeman M. Possible contraceptive use of antiprogestin. Abstract SE77.1. XV FIGO World Congress of Gynecology and Obstetrics, 1997.

9. Catley-Carlson M. Implementating family planning programs in developing countries: lessons and reflections from four decades of Population Council experience. Int J Gynaecol Obstet 1997; Jul: 58(1):101-106.

10. Centchroman. Multicentric trial with biweekly cum weekly dose. Central Drug Research Institute, 1991.

11. Christin et al. Perspectives of contraception. Rev Prat 1995; Dec 1: 45(19): 2449-2453.

12. Cohen E. Study: male pill proves 95% effective. CNN, March 16, 1998.

13. Coleman M. et al. The levonorgestrel-releasing intrauterine device: a wider role than contraception. Aust N Z J Obstet Gynaecol 1997; May: 37(2): 195-201.

14. Contraceptive Method Mix. Guidlines for policy and service delivery. Geneva: WHO, 1994.

15. Coonrod S.A. et al. Monoclonal antibody to human fertilization antigen-1 (FA-1) inhibits bovine fertilization in vitro: application in immunocontraception. Biol Reprod 1994; Jul: 51(1): 14-23: 51(2): 99-110.

16. Davis A.J. Use of depot medroxyprogesterone acetate contraception in adolescents. J Reprod Med 1996; May: 41(5 Sup-pl): 407-413.

17. De Aguilar M. A. et al. Current status of injectable hormonal contraception, with special reference to the monthly method. Adv Contracept 1997; Dec: 13(4): 405-417.

18. Diekman A.B. et al. Sperm antigens and their use in the development of an immunocontraceptive. Am J Reprod Immunol 1997; Jan: 37(1):111-117.

19. Dirnhofer S. et al. Vaccination for birth control. Int Arch Allergy Immunol 1995; Dec: 108(4): 350-354.

20. Eichhorst B.C. Contraception. Prim Care 1988; Sep: 15(3): 437-459.

21. Frank M.L. et al. Levonorgestrel subdermal implants. Contraception on trial. Drug Saf 1997; Dec: 17(6): 360-368.

22. Griffin P.D. The WHO Task Force on Vaccines for Fertility Regulation. Its formation, objectives and research activities. Hum Reprod 1991; Jan: 6(1): 166-172.

23. Grubb G.S. Experimental methods of contraception. Curr Opin Obstet Gynecol 1991; Aug: 3(4): 491-495.

24. Gupta S.K. Prospects of zona pellucida glycoproteins as immunogens for contraceptive vaccine. Hum Reprod Update 1997; Jul: 3(4): 311-324.

25. Handelsman D.J. Hormonal male contraception: progress and prospects for the 21st century. Aust N Z J Med 1995; Dec: 25(6): 808-816.

26. Handelsman D.J. et al. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab 1996; Nov: 81(11): 4113-4121.

27. Heikinheimo O. et al. Mifepristone: a potential contraceptive. Clin Obstet Gynecol 1996; Jun: 39(2): 461-468.

28. Hern P.A. Reversible contraception in female baboons immunized with a synthetic epitope of sperm-specific lactate dehy-drogenase. Biol Reprod 1995; Feb: 52(2): 331-339.

29. Herr J.C. Update on the Center for Recombinant Gamete Contraceptive Vaccinogens. Am J Reprod Immunol 1996; Mar: 35(3): 184-189.

30. Herr J.C. Strategies for development of a sperm antigen-based contraceptive vaccine. Abstract O-130. The 13th Meeting of the ESHRE, 1997.

31. Institute of medicine. "Contraceptive research and development: Looking to the future", 1996.

32. Kamboj V.P. et al. Biological profile of Centchroman; A new post-coital contraceptive. Indian J Exp Biol 1977; 15: 1144- 1150.

33. Katsuki Y. et al. Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid. Drugs Exp Clin Res 1997; 23(2): 45-62.

34. Kerr L.E. Sperm antigens and immunocontraception. Reprod Fertil Dev 1995; 7(4): 825-830.

35. Kessel E. 100 000 quinacrine sterilizations. Abstract SP76.1. XV FIGO World Congress of Gynecology and Obstetrics, 1997.

36. Lobo R.A. et al. New knowledge in the physiology of hormonal contraceptives. Am J Obstet Gynecol 1994; May: 170(5 Pt 2): 1499-1507.

37. Mahajan D.K. et al. Mifepristone (RU486): a review. Fertil Steril 1997; Dec: 68(6): 967-975.

38. Martin C.W. Desogestrel with s.c. testosterone pellets supresses gonadotropins and spermatogenesis without affecting high density leukocyte concentration. Abstract O-210. The 13th Meeting of the ESHRE, 1997.

39. Mishel Jr. D.R. Combinatin OC formulations: worldwide conference report. Abstract SS72.1. XV FIGO World Congress of Gynecology and Obstetrics, 1997.

40. Moudgal N.R. et al. Responsiveness of human male volunteers to immunization with ovine follicle stimulating hormone vaccine: results of a pilot study. Hum Reprod 1997; Mar: 12(3): 457-463.

41. Moudgal N.R. et al. Development of male contraceptive vaccine - a perspective. Hum Reprod Update 1997; Jul: 3(4): 335-346.

42. Muhn P. et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models. Contraception 1995; Feb: 51(2): 99-110.

43. Mullick B.C. et al. Quinacrine sterilization: medroxprogesterone as adjuvant. Abstract SP76.6. XV FIGO World Congress of Gynecology and Obstetrics, 1997.

44. Naz R.K. et al. Development of contraceptive vaccines for humans using antigens derived from gametes (spermatozoa and zona pellucida) and hormones (human chorionic gonadotrophin): current status. Hum Reprod Update 1995; Jan: 1(1): 1-18.

45. Neumann F. Contraception with steroids in the male. Experimental basis, Wien Med Wochenschr 1987; Nov 15: 137(20-21): 492-501.

46. Newton J.R. New hormonal methods of contraception. Baillieres Clin Obstet Gynaecol 1996; Apr: 10(1): 87-101.

47. Perez M.S. et al. Potential contraceptive use of epididymal proteins: evidence for the participation of specific antibodies against rat epididymal protein DE in male and female fertility inhibition. J Reprod Immunol 1995; May: 29(1): 31-45.

48. Reifsnider E. On the horizon: new options for contraception. J Obstet Gynecol Neonatal Nurs 1997; Jan: 26(1): 91-100.

49. Rogers P.A. Endometrial vasculature in Norplant users. Hum Reprod 1996; Oct: 11 Suppl 2: 45-50.

50. Rowland R. Researchers testing new contraceptive ring. CNN, February 22, 1998.

51. Roy S. et al. Induction of ovulation in the human with Centchroman: a preliminary report. Fertil and Steril 1976; 27(9): 1108- 1110.

52. Schmitz et al. Experimental nonsurgical female sterilization: transcervical implantation of microspindles in fallopian tubes. J Vasc Interv Radiol 1994; Nov: 5(6): 905-910.

53. Seregely G. Contraception. Medicina. Budapest 1981, 4th edition;

54. Service R.F. Panel wants to break R&D barrier. Science 31 May 1996; 272: 1258.

55. Singh M. et al. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study. Adv Contracept 1997; Mar: 13(1): 1-11.

56. Skouby S.O. Oral contraceptives: clinical hazards. Abstract SP73.4. XV FIGO World Congress of Gynecology and Obstetrics, 1997.

57. Swahn M.L. Contraception with antiprogesterone. Baillieres Clin Obstet Gynaecol 1996; Apr: 10(1): 43-53.

58. Talwar G.P. et al. Plant immunomodulators for termination of unwanted pregnancy and for contraception and reproductive health. Immunol Cell Biol 1997; Apr: 75(2): 190-192.

59. Talwar G.P. Fertility regulating and immunotherapeutic vaccines reaching human trials stage. Hum Reprod Update 1997; Jul: 3(4): 301-310.

60. UN/WHO/World Bank. Comparative study of the effects of two once-a-month injectable contraceptives on lipid and lipoprotein metabolism. Contraception 1997; Oct: 56(4): 193- 207.

61. Upadhyay S.N. et al. Antifertility effects of neem (Azadirachta indica) oil by single intrauterine administration: a novel method for contraception. Proc R Soc Lond B Biol Sci 1990; Dec: 22: 242(1305): 175-179.

62. Vaidya R. et al. Activity profile of Centchroman in healthy female volunteers. Indian J Exp Biol 1977; 15: 1173-1176.

63. Van Look P.F. Immunocontraception: the science and the politics. Abstract O-131. The 13th Meeting of the ESHRE, 1997.

64. Webb A.M. et al. Comparison of Yuzpe regimen, danazol and mifepristone (RU486) in oral postcoital contraception. Br Med J 1992; 305: 927-31.

65. Weisberg E. et al. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. Contraception 1997; Oct: 56(4): 233-239.

66. Westhoff W.E. et al. In vitro inhibition of the biological activity of follicle-stimulating hormone by antipeptide antisera representing the human follicle-stimulating hormone beta subunit sequence 33-53. Biol Reprod 1997; Feb: 56(2): 460-468.

67. WHO. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; Apr: 65(4): 821-829.

68. Wilson E.W. Sterilization. Baillieres Clin Obstet Gynaecol 1996; Apr: 10(1): 103-119.

69. Zipper J.A. et al. Quinacrine sterilization: development of the metod. Abstract SP76.3. XV FIGO World Congress of Gynecology and Obstetrics, 1997.



Смотрите также: